Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Kahn

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1997
Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3C Spino, J O Kahn, R Dolin, et al.
JAMA|January 8, 1997
HIV-1 protease inhibitors. A review for cliniciansS G Deeks, M Smith, M Holodniy, et al.
Nature Medicine|September 5, 2001
Predicting the unpredictable: transmission of drug-resistant HIVS M Blower, A N Aschenbach, H B Gershengorn, et al.
JAMA|November 1, 2000
Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trialJ O Kahn, D W Cherng, K Mayer, et al.
The Western Journal of Medicine|August 5, 2000
From the cell to the community: AIDS research in California. The University of California Universitywide AIDS Research Program annual meeting, February 2000N E Moss, G Lemp, R Bluthenthal, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trialJ W Tappero, T G Berger, L D Kaplan, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complexG Gatti, J O Kahn, J Lifson, et al.
AIDS Research and Human Retroviruses|December 22, 1999
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccinationC P Locher, R M Grant, E A Collisson, et al.
Blood|January 3, 2001
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapyA M Schito, E Vittinghoff, F M Hecht, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trialJ O Kahn, L D Kaplan, P A Volberding, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1997
Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3C Spino, J O Kahn, R Dolin, et al.
JAMA|January 8, 1997
HIV-1 protease inhibitors. A review for cliniciansS G Deeks, M Smith, M Holodniy, et al.
Nature Medicine|September 5, 2001
Predicting the unpredictable: transmission of drug-resistant HIVS M Blower, A N Aschenbach, H B Gershengorn, et al.
JAMA|November 1, 2000
Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trialJ O Kahn, D W Cherng, K Mayer, et al.
The Western Journal of Medicine|August 5, 2000
From the cell to the community: AIDS research in California. The University of California Universitywide AIDS Research Program annual meeting, February 2000N E Moss, G Lemp, R Bluthenthal, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trialJ W Tappero, T G Berger, L D Kaplan, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complexG Gatti, J O Kahn, J Lifson, et al.
AIDS Research and Human Retroviruses|December 22, 1999
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccinationC P Locher, R M Grant, E A Collisson, et al.
Blood|January 3, 2001
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapyA M Schito, E Vittinghoff, F M Hecht, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trialJ O Kahn, L D Kaplan, P A Volberding, et al.
Pageof 5